Antibiotics are fundamental to modern medicine, essential for treating everything from routine skin infections to strep throat, and for protecting vulnerable patients receiving chemotherapy or being treated in intensive care units. But the proliferation of antibiotic-resistant bacteria—a result of decades of overuse in animal agriculture and human medicine combined with a lack of new drug development and innovation—has placed humanity on the precipice of what public health leaders call a “post-antibiotic” world in which even the most simple surgical procedure could have deadly consequences.
-
Data Visualization
Help Stop Antibiotic Overuse on the Farm
Sign NowOur Work
-
New Antibiotics Bill Addresses the Threat of Superbugs
U.S. Senators Dianne Feinstein (D-CA) and Susan Collins (R-ME) introduced the Preventing Antibiotic Resistance Act on March 2, 2015. The bipartisan legislation would help reduce the public health threat of superbugs by compelling drugmakers to demonstrate that human antibiotics approved for use in livestock to prevent or control disease do not unduly contribute to drug resistance. Read More
-
Antibiotic Use in Human Health Care
Download the infographic Antibiotic Use in Human Health Care (One page PDF) Antibiotic Use in Human Health Care (Two page PDF) Read More
-
Antibiotics Currently in Clinical Development
As of December 2014, an estimated 37 new antibiotics1 that have the potential to treat serious bacterial infections are in clinical development for the U.S. market. The success rate for drug development is low; at best, only 1 in 5 candidates that enter human testing will be approved for patients.* This snapshot of the antibiotic pipeline will be updated periodically as products advance or are... Read More
Focus Areas
